Jim Cramer thinks that Bristol-Myer's deal with Celgene is a positive thing, despite Starboard's resistance.
Bristol-Myers, Tilray, and Elon Musk are some of the top headlines in business news Tuesday. Here's what Jim Cramer's watching.
Here's what you need to know about Tilray's earnings, Elon Musk's fight with the SEC and Bristol-Myers fight with Starboard over Celgene. Jim Cramer talks the markets
An engineered overshoot in inflation may be what the gold market needs right now.
Marriott is making a push towards the high end of the market when consumer spend looks to be slowing. But the hotel operator has some tailwinds at its back.
Matthew Cheslock, an equity trader with Virtu Financial, discusses Lyft's roadshow and the competition between Lyft and Uber, whether or not the Federal Reserve will be even more dovish during their March meeting and why investors should keep an eye on FAANG.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.